A Phase 1, Open-Label, Sequential Cross-over, Bioavailability/Bioequivalence Study to Compare the Pharmacokinetics of Oral Cladribine With the Reference Listed Drug, Intravenous Cladribine
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Hackensack Meridian Health
Medical College of Wisconsin
M.D. Anderson Cancer Center
Emory University
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Institut Curie
Roswell Park Cancer Institute
Fred Hutchinson Cancer Center
Thomas Jefferson University
M.D. Anderson Cancer Center
University of Michigan Rogel Cancer Center
University of Florida
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Loyola University
OHSU Knight Cancer Institute
Weill Medical College of Cornell University
Rutgers, The State University of New Jersey
Duke University
Centre Hospitalier Universitaire de Saint Etienne
Goethe University
Fred Hutchinson Cancer Center
Medical College of Wisconsin
Dana-Farber Cancer Institute
Baylor College of Medicine
Wake Forest University Health Sciences
Memorial Sloan Kettering Cancer Center
Indiana University
Medical College of Wisconsin
University of Liege
M.D. Anderson Cancer Center
Masonic Cancer Center, University of Minnesota
University of Chicago
Fox Chase Cancer Center
Barbara Ann Karmanos Cancer Institute
Washington University School of Medicine
Masonic Cancer Center, University of Minnesota
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Fred Hutchinson Cancer Center
University of Pennsylvania
Jonsson Comprehensive Cancer Center
NYU Langone Health
Masonic Cancer Center, University of Minnesota
University of Florida
M.D. Anderson Cancer Center
Fred Hutchinson Cancer Center
Masonic Cancer Center, University of Minnesota